Here is a sign of the times of American life in the Clinton regime:
"Human embryonic and fetal tissues are available from the Central Laboratory for Human Embryology at the University of Washington. The laboratory, which is supported by the National Institutes of Health, can supply tissue from normal or abnormal embryos and fetuses of desired gestational ages between 40 days and term. Specimens are obtained within minutes of passage and tissues are aseptically identified, staged, and immediately processed according to the requirements of individual investigators. Presently, processing methods include immediate fixation, snap fixation, snap freezing in liquid nitrogen and placement in balanced salt solutions or media designated and/or supplied by investigators. Specimens are shipped by overnight express, arriving the day following procurement. . . .
"Alan G. Fantel, Ph.D.
"Department of Pediatrics, RD-20
"Seattle WA 98195."
In cold, clinical research terms, here is the end product of the "fetal tissue issue" - an economically important byproduct of the sexual revolution.
(For those who want to see the document themselves, it's only a click away on the Internet. Just call up the ask.com search engine, type in "Where can I purchase fetal tissue?," and within seconds, "NIH Guide" will appear as one of the answers.)
Here, courtesy of the National Institutes of Health, in taxpayer-funded black and white, is the reality of America's culture of death: commercial cannibalism of the young of the human species, a business about to break into the mainstream as a coalition of major medical and health organizations, businesses, and associations press for federal funding of lethal embryo research.
Since the widespread legalization of abortion, abortionists, protected and promoted by media publicists, have dramatized the plight of the poor pregnant girl whose life can only be set right by free and easy access to tax-funded abortions.
The abortion industry, however, has always been about money, and now Houston-based Life Dynamics has shown it's a double-profiteering, body-snatching supplier for the rapidly growing biologics and pharmacological industries which require a continuing supply of fresh human bodies, brains, organs, flesh and bones for research, product manufacturing, treatments, and therapies.
Following the release, last May, of a powerful LifeTalk video featuring "Kelly," a fetal tissue procurer for the Maryland-based Anatomic Gifts Foundation, Life Dynamics has released documentation obtained from fetal tissue wholesalers, that is, companies which place their employees in abortion facilities to harvest tissue, limbs, organs, etc. The tissue is then shipped to universities, pharmaceutical and biologics firms, and government research centers.
Included in the documents are price lists and shipping and procurement instructions.
Opening Lines, a division of Consultative and Diagnostic Pathology, Inc., of West Frankfurt, Ill., will pay $999 for brains eight weeks old or less ("30% discount if significantly fragmented"), $400 for an intact embryonic cadaver eight weeks old or less; $600 for an intact embryonic cadaver above eight weeks; $550 for gonads; $350 for bone marrow, and various prices for everything but the scream: livers, spleens, pancreas, thymus, mesentery, kidney, pituitary gland, ears, eyes, skin, lung and heart block, spinal column, spinal cord, cord blood, limbs.
Anatomic Gift Foundation will pay $220 for a first-trimester aspiration abortion ("fresh") and $260 if it is "frozen."
Opening Lines provides two kinds of promotional literature, brochures for abortion clinics and brochures for researchers and industry, which Life Dynamics includes in its booklet of documentation.
The front page of the brochure for abortion facilities proclaims: "Find out how you can turn your patients' decision into something wonderful." Inside is this text: "We know your patient's decision to have an abortion was carefully considered and we also know it was a very difficult one to make.
"Now that the choice has been made, we ask that you propose to your patient a simple program that could help thousands of people. . . .
"Consultative and Diagnostic Pathology, Inc., will be asking to obtain tissue specimens from your patient's medical procedure. . . .
"This is an opportunity to make a difference . . . and it can be beneficial to your clinic. . . .
"1) Consultative and Diagnostic Pathology will lease space from your facility to perform the harvesting and distribution of tissue. The revenue generated from the lease can be used to offset your clinic's overhead.
"2) Consultative and Diagnostic Pathology can train your staff to harvest and process fetal tissue. Based on your volume we will reimburse part or all of your employee's salary, thereby reducing your overhead."
The brochure for industry declares: "Fresh Fetal Tissue harvested and shipped to your specifications . . . where and when you need it."
The company boasts its tissue "is the highest quality, most affordable, and freshest tissue prepared to your specifications and delivered in the quantities you need when you need it."
Also included in the Life Dynamics booklet are dozens of copies of completed "tissue requested" documents, along with protocols for harvesting, preserving, and shipping.
One such document is a request for "Limbs, Liver, Thymus."
"Preservation: Fresh shipped on wet ice. IMDM/10%, lx l-Glutamine, Pen/Strep. Will supply if necessary. Limbs intact. To be removed under sterile conditions. . . .
"Shipping: Fresh, wet ice. Priority overnight or same day.
"Tissue Use/Significance: Human fetal tissue will be used for the generation of SCID-humice. Briefly, a SCID mouse is engrafted with either a human bone marrow fragment, thymus/liver graft, or a lymph node. These mice will then be used to study hemoglobinopatheis in vivo. . . . Approval for the production of SCID humice and transplantation of cells into them has already been obtained from the IUCUC of Genetech, Inc. (Study #97-156)."
Other documents stipulate that organs must be retrieved within ten minutes, indicating that the organ must be procured from a living, aborted baby.
Other documents stipulate "no dig," which instructs the abortionist that no digoxin (a feticidal chemical) can be used, for it would harm the desired organs.
Other norms stipulate "no anomalies" or "no congenital abnormalities" - evidence perfectly healthy babies are being aborted for organ harvesting.
Life Dynamics also discloses that these fetal organ harvesting businesses set up promotional booths at conferences held by the National Abortion Federation.
Much of the fetal tissue is used for HIV/AIDS research.
Technically, this gruesome business is illegal. It is against federal law to sell human tissue or body parts, but as Life Dynamics points out: "The fetal material [the companies] harvest is `donated' to them by the clinics. However, they do pay a `site fee' to the clinics for the right to access the tissue.
"The tissue is then `donated' to the researchers who in turn pay the wholesalers for the cost of retrieval. Profit is realized by the wholesalers' ability to set their own retrieval fees."
Fetal tissue research, harvesting organs from living, aborted babies, building "humice" for research and the rest of the brave new world of biomedical research is not new; the work goes back to the 1920s, according to the American Life League's Judie Brown in "Recycling Babies: The Practice of Fetal Tissue Research" (1996).
In the American Life League's Pro-Life Activist's Encyclopedia entry on "Fetal Experimentation: Frankenstein Revisited," author Brian Clowes traces the gruesome history of fetal experimentation and organ harvesting - the "road to Auschwitz" - back to European and U.S. universities in the 1960s. The practice rapidly accelerated with the legalization of abortion.
On May 20th, a coalition called Patients' CURe (Coalition for Urgent Research) started lobbying in Washington, D.C., for federal taxpayer funding of stem cell research that requires the killing of human embryos, accompanied by an enormous media blitz ballyhooing the alleged benefits of fetal tissue research for a host of medical problems.
Members of the coalition include the Alliance for Aging Research, the American Cancer Society, the Glaucoma Research Council, Juvenile Diabetes Foundation International, Parkinson's Action Network, Resolve: The National Infertility Association, and the Spina Bifida Association, Inc.
As Richard Doerflinger of the U.S. Bishops' Pro-Life Activities office observed, the demand for federal funding for destructive embryo research - currently against the law - represents a dramatic turn in the American abortion culture: Government now can only fund those abortions which "save the life of the mother," but under proposed legislation, will fund abortions that "produce lifesaving benefits for others."
Clowes estimates that, with the aging of America and the growing callousness of baby-boomers, there will be an increased demand for medical treatments using organs and tissue harvested from aborted babies.
"It may be expected," he wrote in ALL's Encyclopedia, "that as many as five million people will make use of fetal tissue on a regular basis. This means that the total amount of fetal tissue required to satisfy the demands of these 'neo-vampires' will be measured in the tons every year.
"Since there are only about 120,000 second and third trimester abortions in the United States, this means that demand for fetal tissue will crushingly and inevitably overwhelm the available supply."
Clowes predicted "inflated prices . . ., a thriving black market; the growing and selling of preborn babies for sale; the import of fetal tissue from poor and developing countries; and entrepreneurs encouraging women to abort as late as possible for a monetary reward."
Clowes wrote the above in 1995.
In 1999, Kelly, the pseudonymous organ harvester who unloaded her documents at Life Dynamics, confirmed that women are "coerced" into having abortions. Women, she says, would change their minds after entering the abortion mills, but they were sedated by staff into a "Nyquil nap."
Kelly also testified on the Life Dynamics video that women are encouraged to have late-term abortions to meet the demands of an industry that requires intact specimens and tissues.
Mark Crutcher, president of Life Dynamics, says he's convinced that the reason the abortion industry fights so hard to keep "partial-birth abortion" legal is that it wants to sell the fetal tissue.
"Why do pro-aborts fight so hard to keep it?," he asks in an interview published last month in The Alberta Report. "All it says is you can't kill them by this method. . . .
"This is about maximizing profits. First, you sell the woman an abortion. Then you turn around and sell the dead baby you take out of her. But you have to take it out whole or you don't have anything to sell."
Source: The Wanderer (Issue Date of 9-30-99)